Skip to main content

Xeris Biopharma Holdings, Inc.

XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867096

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of XERS: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders142135−7
Shares60.5M60.7M+206.4K (+0.3%)
Value$133.7M$136.6M+$2.87M (+2.1%)

New holders (16)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to XERS in Q2 2024
InstitutionSharesValue% of portfolio
Corebridge Financial, Inc.75,441$169.7K0.00%
Verition Fund Management LLC74,234$167.0K0.00%
Mirae Asset Global ETFs Holdings Ltd.66,707$150.1K0.00%
Powell Investment Advisors, LLC50,000$112.5K0.06%
State Board of Administration of Florida Retirement System37,970$85.4K0.00%
Sanctuary Advisors, LLC33,429$58.5K0.00%
Franklin Resources Inc19,488$43.8K0.00%
Two Sigma Securities, LLC12,900$29.0K0.00%
Simplicity Wealth,LLC12,156$27.4K0.00%
Bleakley Financial Group, LLC12,156$27.4K0.00%
TownSquare Capital, LLC11,267$25.4K0.00%
Mirae Asset Global Investments Co., Ltd.4,426$10.0K0.00%
SRS Capital Advisors, Inc.1,632$3.67K0.00%
Activest Wealth Management1,000$2.25K0.00%
Nisa Investment Advisors, LLC379$8530.00%
Rothschild Investment LLC125$2810.00%

Sold out (23)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.